Cargando…
Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension
Prostacyclin analogs are among the most effective and widely used therapies for pulmonary arterial hypertension (PAH). However, it is unknown whether they also confer protection through right ventricle (RV) myocardio-specific mechanisms. Moreover, the use of prostacyclin analogs in severe models of...
Autores principales: | Vanderpool, Rebecca R., Gorelova, Anastasia, Ma, Yiran, Alhamaydeh, Mohammad, Baust, Jeffrey, Shiva, Sruti, Tofovic, Stevan P., Hu, Jian, Nouraie, Seyed Mehdi, Gladwin, Mark T., Sharifi-Sanjani, Maryam, Al Ghouleh, Imad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141343/ https://www.ncbi.nlm.nih.gov/pubmed/35628236 http://dx.doi.org/10.3390/ijms23105426 |
Ejemplares similares
-
Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation
por: Sharifi-Sanjani, Maryam, et al.
Publicado: (2021) -
The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling
por: Vanderpool, Rebecca R., et al.
Publicado: (2023) -
Experimental intravascular hemolysis induces hemodynamic and
pathological pulmonary hypertension: association with accelerated purine
metabolism
por: Bilan, Victor P., et al.
Publicado: (2018) -
Recent advancements in pulmonary arterial hypertension and right
heart failure research: overview of selected abstracts from ATS2020 and emerging
COVID-19 research
por: Potus, Francois, et al.
Publicado: (2021) -
Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension
por: Martin, Brian, et al.
Publicado: (2021)